Key Summary
- Stoke Mandeville Hospital performs Europe’s first Intracept procedure
- Minimally invasive treatment for chronic vertebrogenic back pain, with 75% long-term success
- Supports NHS 10-Year Plan by expanding access to innovative care
Buckinghamshire Healthcare NHS Trust has rolled out Europe’s first-ever Intracept procedure to treat back pain, at Stoke Mandeville Hospital.
The historic procedure carried out by Dr David McKean, clinical lead for radiology, is a minimally invasive cure for chronic vertebrogenic low back pain.
Over 5.5 million people in the UK suffer from this condition.
The pain is a result of lower spine damage, which is mostly unresponsive to treatments.
The procedure heats small nerve (basivertebral nerve) in the spine that signals about pain to the brain.
It disrupts the signals, helping the patients to have free movements.
Studies have proven that 75 percent people experienced long-term improvement.
This achievement supports the NHS 10-Year Plan by improving access to innovative treatments.
“Intracept stands out as the only procedure uniquely engineered to target vertebrogenic pain, a condition often overlooked in traditional back pain therapies,” said Dr McKean, clinical lead for radiology at the trust.
“It highlights our Trust’s dedication to leading the way in delivering innovative and outstanding care to our patients in Buckinghamshire,” added Andrew McLaren, chief medical officer at the trust.
